Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 7YJ3 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with human ACE2 (local refinement) | |
| 8H06 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 RBD in complex with human ACE2 (local refinement) | |
| 8H5C | Q9BYF1 | Structure of SARS-CoV-2 Omicron BA.2.75 RBD in complex with human ACE2 | |
| 8FXB | Q9BYF1 | SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8FXC | Q9BYF1 | SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8S9G | Q9BYF1 | SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 7EFR | Q9BYF1 | Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T27W,N330Y) | |
| 7EKC | Q9BYF1 | Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2 | |
| 7EKF | Q9BYF1 | Structure of SARS-CoV-2 Alpha variant spike receptor-binding domain complexed with human ACE2 | |
| 7EKG | Q9BYF1 | Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2 | |
| 7SY4 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
| 8AQS | Q9BYF1 | BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local) | |
| 7SY5 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) | |
| 7SY7 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) | |
| 7V82 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1 | |
| 7V82 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1 | |
| 7R10 | Q9BYF1 | Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 | |
| 7R1A | Q9BYF1 | Furin Cleaved Alpha Variant SARS-CoV-2 Spike in complex with 3 ACE2 | |
| 7TEZ | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
| 7TEX | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 | |
| 7TF0 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 | |
| 7U0N | Q9BYF1 | Crystal structure of chimeric omicron RBD (strain BA.1) complexed with human ACE2 | |
| 7ZDQ | Q9BYF1 | Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant | |
| 8DLJ | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 | |
| 8DLM | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 | |
| 7Y76 | Q9BYF1 | SIT1-ACE2-BA.5 RBD | |
| 7XBF | Q9BYF1 | The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2 | |
| 7XBG | Q9BYF1 | The crystal structure of RshSTT182/200 RBD-insert2-T346R-Y496G mutant in complex with human ACE2 | |
| 7XBH | Q9BYF1 | The complex structure of RshSTT182/200 RBD bound to human ACE2 | |
| 8ASY | Q9BYF1 | SARS-CoV-2 Omicron BA.2.75 RBD in complex with ACE2 | |
| 8DM5 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 | |
| 8DM6 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
| 7Y1Y | Q9BYF1 | S-ECD (Omicron BA.2) in complex with PD of ACE2 | |
| 7Y1Z | Q9BYF1 | S-ECD (Omicron BA.3) in complex with three PD of ACE2 | |
| 8WTD | Q9BYF1 | XBB.1.5.10 RBD in complex with ACE2 | |
| 7SXY | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
| 7SY1 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) | |
| 7SY2 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
| 7T9K | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 | |
| 7R0Z | Q9BYF1 | Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
| 7R11 | Q9BYF1 | Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
| 7R12 | Q9BYF1 | Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
| 7WPA | Q9BYF1 | SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2 | |
| 7WPB | Q9BYF1 | SARS-CoV-2 Omicron Variant RBD complexed with ACE2 | |
| 7WPC | Q9BYF1 | The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2 | |
| 7XID | Q9BYF1 | S-ECD (Omicron) in complex with PD of ACE2 | |
| 7XO7 | Q9BYF1 | SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound | |
| 7XO8 | Q9BYF1 | SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound | |
| 7XO9 | Q9BYF1 | SARS-CoV-2 Omicron BA.2 Variant RBD complexed with human ACE2 | |
| 7V61 | Q9BYF1 | ACE2 -Targeting Monoclonal Antibody as Potent and Broad-Spectrum Coronavirus Blocker |
